$5.90
-0.35-5.6%
Last update: Nov 4, 7:00 PM
Emergent BioSolutions Inc
EBSNYSE
The average analyst price target for Emergent BioSolutions is $13.50, 122.8% above the current price. Of 4 analysts, 3 rate it Buy and 1 Sell. Targets range from $10 to $16. The latest change came on Aug 10, 2026, when HC Wainwright & Co. lowered its price target on Emergent BioSolutions from $12 to $10 and kept a Buy rating.
Price Target Range — 10 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
